-
公开(公告)号:WO2022013408A2
公开(公告)日:2022-01-20
申请号:PCT/EP2021/069897
申请日:2021-07-15
Applicant: MERCK SHARP & DOHME CORP. , MSD R&D INNOVATION CENTRE LIMITED , ALTMAN, Michael , CANDITO, David, A. , CHRISTIAN, Alec, H. , DI PIETRO, Ornella , LU, Min , LUI, Ping , MANSOOR, Umar, Faruk , MENNIE, Katrina, Marie , MUSACCHIO, Andrew, J. , PALANI, Anandan , REUTERSHAN, Michael, H. , SHAW, David, Matthew , ST-GALLAY, Stephen
Inventor: ALTMAN, Michael , CANDITO, David, A. , CHRISTIAN, Alec, H. , DI PIETRO, Ornella , LU, Min , LIU, Ping , MANSOOR, Umar, Faruk , MENNIE, Katrina, Marie , MUSACCHIO, Andrew, J. , PALANI, Anandan , REUTERSHAN, Michael, H. , SHAW, David, Matthew , ST-GALLAY, Stephen
IPC: C07C255/46 , A61P25/00 , C07D205/12 , C07D221/20 , C07D295/185 , C07D307/94 , C07D311/96 , C07D403/02 , C07D413/02 , C07D491/048 , A61K31/4747 , A61K31/277
Abstract: The present invention relates to cyclic cyanoenone derivatives of Formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R1, R2, R3, R4 and m are as defined herein. The present invention also relates to pharmaceutical compositions comprising the cyclic cyanoenone derivatives of Formula (I) and to their use in therapy.
-
公开(公告)号:WO2008122765A1
公开(公告)日:2008-10-16
申请号:PCT/GB2008/001171
申请日:2008-04-04
Applicant: ASTRAZENECA AB , ASTRAZENECA UK LIMITED , HALLAM, Matthew , MARTIN, Barrie , RAUBO, Piotr , ROBERTS, Bryan , ST-GALLAY, Stephen , WILLIS, Paul
Inventor: HALLAM, Matthew , MARTIN, Barrie , RAUBO, Piotr , ROBERTS, Bryan , ST-GALLAY, Stephen , WILLIS, Paul
IPC: C07D217/24 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D487/08 , A61K31/4353 , A61P11/06
CPC classification number: C07D217/24 , C07D217/26 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D487/08
Abstract: The present invention relates to isoquinolinone derivatives of formula (I): should be wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Abstract translation: 本发明涉及式(I)的异喹啉酮衍生物:其中R 1,R 2,R 3,R 3, R 4,R 5,R 6和R 7如本文所定义; 其制备方法,含有它们的药物组合物及其在治疗中的用途。
-
公开(公告)号:WO2010039079A1
公开(公告)日:2010-04-08
申请号:PCT/SE2009/000432
申请日:2009-10-01
Applicant: ASTRAZENECA AB , BROUGH, Stephen, John , LUKER, Timothy, Jon , ROBERTS, Bryan, Glyn , ST-GALLAY, Stephen, Anthony
Inventor: BROUGH, Stephen, John , LUKER, Timothy, Jon , ROBERTS, Bryan, Glyn , ST-GALLAY, Stephen, Anthony
IPC: C07D401/06 , A61K31/472 , A61K31/4725 , A61K31/496 , A61K31/55 , A61P11/06 , C07D217/24
CPC classification number: C07D401/12 , C07D217/24 , C07D401/06
Abstract: The present invention relates to isoquinolinone derivatives of formula (I): wherein are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Abstract translation: 本发明涉及式(I)的异喹啉酮衍生物:其中如本文所定义; 其制备方法,含有它们的药物组合物及其在治疗中的用途。
-
公开(公告)号:WO0119828A3
公开(公告)日:2001-10-04
申请号:PCT/US0025357
申请日:2000-09-15
Applicant: BASF AG , HIRST GAVIN C , RAFFERTY PAUL , RITTER KURT , CALDERWOOD DAVID , TWIGGER HELEN L , ST GALLAY STEPHEN
Inventor: HIRST GAVIN C , RAFFERTY PAUL , RITTER KURT , CALDERWOOD DAVID , TWIGGER HELEN L , ST GALLAY STEPHEN
IPC: A61K31/437 , A61K31/5025 , A61K31/519 , A61K31/55 , A61K38/00 , A61P1/18 , A61P3/10 , A61P7/06 , A61P9/00 , A61P9/10 , A61P15/00 , A61P17/02 , A61P17/06 , A61P19/02 , A61P27/02 , A61P29/00 , A61P31/12 , A61P31/18 , A61P33/02 , A61P35/00 , A61P35/02 , A61P37/02 , C07D471/04 , C07D487/04 , C07F9/6561 , A61K31/4353 , A61K31/551 , C07D491/04 , C07D498/04
CPC classification number: C07D471/04 , C07D487/04 , C07F9/6561
Abstract: The present invention is directed to a compound of Formula (I) as defined herein which are useful as kinase inhibitors.
Abstract translation: 本发明涉及可用作激酶抑制剂的本文定义的式(I)化合物。
-
公开(公告)号:IL201015D0
公开(公告)日:2010-05-17
申请号:IL20101509
申请日:2009-09-17
Applicant: ASTRAZENECA AB , ROBERTS BRYAN , WILLIS PAUL , HALLAM MATTHEW , MARTIN BARRIE , RAUBO PIOTR , ST GALLAY STEPHEN
IPC: C07D20100101
Abstract: The present invention relates to isoquinolinone derivatives of formula (I): wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
-
-
-
-